3 Stocks to Get on Your Watchlist
A biotech with a newly approved drug, a potentially cheap banking giant, and a possibly overvalued clinical-stage biotech with a promising rare-disease drug are this week's must-watch stocks.
The 3 Biggest Biotech Wins of the Week
See who released the best clinical results during the week ending May 25.
This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks
Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.